Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Department of Biochemistry, University of Washington, Seattle, Washington, USA.
mSphere. 2020 Dec 16;5(6):e01125-20. doi: 10.1128/mSphere.01125-20.
The type II secretion system (T2SS) is a conserved transport pathway responsible for the secretion of a range of virulence factors by many pathogens, including Disruption of the T2SS genes in results in loss of secretion, changes in cell envelope function, and growth defects. While T2SS mutants are viable, high-throughput genomic analyses have listed these genes among essential genes. To investigate whether secondary mutations arise as a consequence of T2SS inactivation, we sequenced the genomes of six T2SS mutants with deletions or insertions in either the , , or genes and identified secondary mutations in all mutants. Two of the six T2SS mutants contain distinct mutations in the gene encoding the T2SS-secreted protease VesC. Other mutations were found in genes coding for cell envelope proteins. Subsequent sequence analysis of the gene in 92 additional T2SS mutant isolates identified another 19 unique mutations including insertions or deletions, sequence duplications, and single-nucleotide changes resulting in amino acid substitutions in the VesC protein. Analysis of VesC variants and the X-ray crystallographic structure of wild-type VesC suggested that all mutations lead to loss of VesC production and/or function. One possible mechanism by which T2SS mutagenesis can be tolerated is through selection of -inactivating mutations, which may, in part, suppress cell envelope damage, establishing permissive conditions for the disruption of the T2SS. Other mutations may have been acquired in genes encoding essential cell envelope proteins to prevent proteolysis by VesC. Genome-wide transposon mutagenesis has identified the genes encoding the T2SS in as essential for viability, but the reason for this is unclear. Mutants with deletions or insertions in these genes can be isolated, suggesting that they have acquired secondary mutations that suppress their growth defect. Through whole-genome sequencing and phenotypic analysis of T2SS mutants, we show that one means by which the growth defect can be suppressed is through mutations in the gene encoding the T2SS substrate VesC. VesC homologues are present in other species and close relatives, and this may be why inactivation of the T2SS in species such as , sp. strain 60, and also results in a pleiotropic effect on their outer membrane assembly and integrity.
II 型分泌系统(T2SS)是一种保守的运输途径,负责许多病原体分泌一系列毒力因子,包括 。破坏 中的 T2SS 基因会导致分泌丧失、细胞包膜功能改变和生长缺陷。虽然 T2SS 突变体是可行的,但高通量基因组分析将这些基因列为必需基因。为了研究 T2SS 失活是否会导致继发突变,我们对 中的六个缺失或插入 、 或 基因的 T2SS 突变体进行了基因组测序,并在所有突变体中发现了继发突变。六个 T2SS 突变体中的两个含有编码 T2SS 分泌蛋白酶 VesC 的基因中的不同突变。其他突变发生在编码细胞包膜蛋白的基因中。随后对 92 个额外的 T2SS 突变体分离株中的 基因进行序列分析,确定了另外 19 个独特的突变,包括插入或缺失、序列重复和导致 VesC 蛋白中氨基酸取代的单核苷酸变化。VesC 变体分析和野生型 VesC 的 X 射线晶体结构分析表明,所有突变都导致 VesC 产生和/或功能丧失。T2SS 诱变可以耐受的一种可能机制是选择 失活突变,这可能部分抑制细胞包膜损伤,为 T2SS 破坏建立许可条件。其他突变可能发生在编码必需细胞包膜蛋白的基因中,以防止 VesC 的蛋白水解。全基因组转座子诱变已确定 中的基因编码 T2SS 对生存力至关重要,但原因尚不清楚。这些基因缺失或插入的突变体可以被分离出来,这表明它们获得了可以抑制生长缺陷的继发突变。通过对 T2SS 突变体的全基因组测序和表型分析,我们表明,抑制生长缺陷的一种方法是通过编码 T2SS 底物 VesC 的基因发生突变。VesC 同源物存在于其他 物种和近亲中,这可能是为什么 种、 sp. 菌株 60 和 等物种中 T2SS 的失活也会对其外膜组装和完整性产生多效性影响的原因。